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Vitamin A and Feeding Statuses Modulate the Insulin-
Regulated Gene Expression in Zucker Lean and Fatty
Primary Rat Hepatocytes
Wei Chen, Meredith L. Howell, Yang Li, Rui Li, Guoxun Chen*
Department of Nutrition, University of Tennessee at Knoxville, Knoxville, Tennessee, United States of America
Abstract
Unattended hepatic insulin resistance predisposes individuals to dyslipidemia, type 2 diabetes and many other metabolic
complications. The mechanism of hepatic insulin resistance at the gene expression level remains unrevealed. To examine
the effects of vitamin A (VA), total energy intake and feeding conditions on the insulin-regulated gene expression in primary
hepatocytes of Zucker lean (ZL) and fatty (ZF) rats, we analyze the expression levels of hepatic model genes in response to
the treatments of insulin and retinoic acid (RA). We report that the insulin- and RA-regulated glucokinase, sterol regulatory
element-binding protein-1c and cytosolic form of phosphoenolpyruvate carboxykinase expressions are impaired in
hepatocytes of ZF rats fed chow or a VA sufficient (VAS) diet ad libitum. The impairments are partially corrected when ZF
rats are fed a VA deficient (VAD) diet ad libitum or pair-fed a VAS diet to the intake of their VAD counterparts in non-fasting
conditions. Interestingly in the pair-fed ZL and ZF rats, transient overeating on the last day of pair-feeding regimen changes
the expression levels of some VA catabolic genes, and impairs the insulin- and RA-regulated gene expression in
hepatocytes. These results demonstrate that VA and feeding statuses modulate the hepatic insulin sensitivity at the gene
expression level.
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Introduction
The liver is critical for glucose and lipid homeostasis, which is
achieved partially through the regulation of hepatic gene
expression in response to hormonal and nutritional stimuli [1,2].
The disturbance of these responses may lead to the development of
metabolic diseases, including obesity and type 2 diabetes [1]. Even
though the pathogenesis of these diseases has not been fully
elucidated, insulin resistance is a common feature [3]. Current
theory postulates that overnutrition triggers system inflammation,
dysregulates lipid metabolism, and alters gastrointestinal microbi-
ota, all of which may interplay and lead to impaired insulin action
in the body [4].
The insulin-regulated hepatic metabolism is partially attributed
to the regulation of hepatic genes expression. For instance, in
primary rat hepatocytes, insulin induces the glucokinase (GCK,
gene Gck) expression to promote glycolysis and suppresses the
phosphoenolpyruvate carboxykinase (PEPCK-C, gene Pck1)
expression to reduce gluconeogenesis [5,6]. Insulin also induces
hepatic lipogenesis via inducing sterol regulatory element-binding
protein 1c (SREBP-1c, gene Srebp-1c) expression. SREBP-1c
stimulates the expression of hepatic lipogenic genes, such as acetyl-
coenzyme A carboxylase and fatty acid synthase [7]. In the insulin-
resistant liver, insulin is unable to suppress the expression of
gluconeogenic genes. But it is able to concurrently induce the
expression of lipogenic genes [2]. This phenomenon demonstrates
the coexistence of hyperglycemia and hyperlipidemia in type 2
diabetes.
As an essential and lipophilic micronutrient, vitamin A (VA,
retinol) is implicated in the regulation of glucose and lipid
metabolism [1]. Two stepwise cytosolic enzymatic reactions
convert retinol to retinal and then into retinoic acid (RA, all-
trans RA or 9-cis RA), which then enters the nucleus and modules
gene expression through the activation of retinoid acid receptors
and retinoid X receptors [8]. We have reported that the insulin-
regulated gene expression is impaired in primary hepatocytes from
Zucker fatty (ZF) rats fed ad libitum [9]. Recent reports by our
group also show that RA synergizes with insulin to induce the Gck
and Srebp-1c expressions in primary rat hepatocytes [10,11]. RA
attenuates the insulin-suppressed Pck1 expression in the same cells
[12]. These data suggest that micronutrient status can affect
hepatic insulin sensitivity at the gene expression level. However,
the roles of caloric intake and micronutrient composition in the
hepatic insulin resistance at the gene expression level have not
been investigated.
Here, we chose Zucker lean (ZL) and ZF rats as insulin sensitive
and resistant models, respectively, to investigate the effects of
energy intake and VA status on the hepatic insulin sensitivity at the
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gene expression level. We demonstrate that VA deficiency partially
corrects the impaired insulin-regulated gene expression in ZF
primary hepatocytes. More importantly, transient overeating in
ZL and ZF rats causes the impairment of insulin-regulated gene
expression in their primary hepatocytes.
Materials and Methods
Reagents
The reagents for primary hepatocyte isolation and culture
including Medium 199, Dulbecco’s Modification of Eagle Medium
(DMEM), liver perfusion buffer and liver digest buffer were
obtained from Invitrogen (Carlsbad, CA). For RNA extraction,
RNA STAT-60 was purchased from TEL-TEST (Friendswood,
TX). The reagents for cDNA synthesis and real-time PCR were
obtained from Applied Biosystems (Foster city, CA). All real-time
PCR primer sets used in this study were synthesized by Sigma-
Aldrich (St. Louis, MO). All other reagents and materials were
purchased from Fisher Scientific (Pittsburgh, PA) unless described
otherwise.
Animals and rodent diets
Zucker rats (Harlan Laboratories) were bred and housed on a
12 hour light-dark cycle under constant temperature and humidity
in the animal facility at University of Tennessee at Knoxville.
Breeding pairs were kept on Teklad rodent chow (#8640, Harlan
Laboratories, Indianapolis, IN). Weaned male ZL (fa/+ or +/+)
and ZF (fa/fa) rats (21 days old) were fed experimental diets for 8
weeks before primary hepatocyte isolation. Synthetic VA sufficient
(VAS, #5755, 22.1 IU/g VA) and VA deficient (VAD, #5822,
0 IU/g VA) diets were isocaloric diets from TestDiet (Richmond,
VA). All procedures (Protocol #1256, #1863) were approved by
the Institutional Animal Care and Use Committee at the
University of Tennessee at Knoxville.
Pair-feeding study
Male ZL or ZF rats (VAD-AD group, and VAD ad libitum, 5
rats per group) had free access to the VAD diet and water for 56
days. The body mass and food intake were recorded every 2 days.
Primary hepatocytes were isolated on Day 56. Two pair-feeding
groups were set up to circumvent a potential caveat on the last day
of pair-feeding. Since VAD animals consume significantly less diet
than their VAS counterparts in ad libitum feeding condition [13–
15], the VAS pair-fed rats would conceivably consume the last
day’s ration rapidly. This caveat would result in a fasting status in
these rats and affect the analysis of insulin-regulated hepatic gene
expression. Therefore, 10 rats with matching genotypes were
paired up with rats in VAD-AD group according to weaning body
mass. They were pair-fed the VAS diet for 55 days to the intakes of
their VAD-AD counterparts. During the course of pair-feeding,
unfinished food pellets were rolled over to ensure that equal total
calories were provided. The body mass and food intake of these
rats were recorded daily. On Day 56, one group, VAS-PF-AD
(VAS pair-feeding last day ad libitum), was allowed to have free
access to the VAS diet to prevent fasting energy status. The other
group, VAS-PF-4M (VAS pair-feeding last day 4 meals), was fed
the VAS diet to the amount consumed by the VAD-AD group.
One fourth of the ration was provided to VAS-PF-4M rats every
6 hours, so that they remained non-fasted energy status till the end
of the study. Before primary hepatocyte isolation, the tail tip whole
blood glucose was measured using a LifeScan OneTouch
Ultramini glucometer (Milpitas, CA).
Primary hepatocyte isolation
The primary hepatocytes were isolated according to previously
described protocol [9]. The rat was euthanized by primary carbon
dioxide asphyxiation, and then secondary cervical dislocation
according to the protocol. A peristaltic pump with the flow rate of
10 ml/min was set up to infuse about 120 ml liver perfusion buffer
and 120 ml liver digestion buffer. A catheter connected to the
pump was inserted into the portal vein. The inferior vena cava was
punctured to allow the outflow of blood and buffers. The liver was
then excised and put into a cell culture dish containing liver
digestion buffer to remove connective tissues. The released
hepatocytes were filtered through a 100 mm cell strainer and
collected by 506 g centrifugation for 3 minutes. The hepatocytes
were washed twice with high glucose DMEM containing 8% fetal
bovine serum, 1% penicillin/streptomycin. Isolated hepatocytes
were seeded on 60-mm collagen type I coated dishes at 26106 cells
per dish and incubated in high glucose DMEM containing 8%
fetal bovine serum, 1% penicillin/streptomycin at 37uC and 5%
CO2 for 3 hours. The attached hepatocytes were washed once
with PBS and pretreated in medium A (Medium 199 with 100 nM
dexamethasone, 100 nM 3,39,5-triiodo-L-thyronine (T3), and 1%
penicillin/streptomycin) containing 1 nM insulin at 37uC and 5%
CO2 for 14–16 hours.
Insulin and RA treatments, RNA extraction and real-time
PCR
The pretreated hepatocytes were washed once with PBS, and
then treated for 6 hours at 37uC and 5% CO2 with medium A
containing indicated concentrations of insulin (0 nM to 100 nM)
with or without 5 mM RA. The methods for total RNA extraction
and cDNA synthesis were described elsewhere [16]. In essence,
total RNA was extraction from the treated hepatocytes with RNA
STAT-60 according to the manufacture’s protocol. The contam-
inated DNA in RNA samples was removed using the DNA-free
kit. First strand cDNA was synthesized with 2 mg total RNA by
cDNA synthesis kit. The gene expression level was determined by
real-time PCR with respective primer sets, and normalized to the
mRNA level of ribosomal gene 36B4. The data were presented as
either minus D cycle threshold (Ct) or the induction fold (DDCt) for
which the control treatment group was arbitrarily set as 1.
Statistical analysis
Statistical analyses were performed using SPSS 19.0 software.
Student t-test was used to compare the means between two
treatments. One-way ANOVA with LSD post-hoc test was used to
compare the means of three or more treatments. Two-way
ANOVA with Bonferroni’s post-hoc test was used to determine the
effects of diets and genotypes on hepatic gene expression. Data
were presented as means 6 S.E.M. The number of experiments
indicates hepatocyte isolations from different animals. A p value
less than 0.05 is considered statistically significant.
Results
The insulin- and RA-regulated Gck, Pck1, and Srebp-1c
expressions were impaired in primary hepatocytes from
ZF rats fed chow ad libitum
We compared the insulin-regulated gene expression in primary
hepatocytes from ZL and ZF rats fed chow ad libitum. Insulin
dose-dependently induced the Gck and Srebp-1c expressions
(Figure 1A and 1C), and suppressed the Pck1 expression
(Figure 1B) in ZL hepatocytes. RA (5 mM) synergized with insulin
to induce the Gck and Srebp-1c expressions (Figure 1A and 1C).
Vitamin A and Feeding Statuses Modulate Hepatic Insulin Sensitivity
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The elevated Pck1 level in the presence of RA was still lowered by
insulin at 1 nM or higher (Figure 1B). Comparably in ZF
hepatocytes, the fold inductions of Gck expression by insulin
(marked by *) and RA + insulin (marked by #) at the
corresponding concentrations were significantly lower than that
in ZL hepatocytes (Figure 1A). The inductions of Srebp-1c by
insulin (0.1 to 100 nM) and RA + insulin (0.1 to 100 nM) were
abolished in ZF hepatocytes (Figure 1C). Additionally, the insulin-
mediated suppression of Pck1 was less profound in ZF hepatocytes
compared with that in ZL hepatocytes (Figure 1B, marked by *
and #, and Figure S1 in File S1). Furthermore, the expressions of
liver type pyruvate kinase gene (Pklr) in primary hepatocytes from
either ZL or ZF rats were not affected by insulin and RA
treatments (Figure 1D). These data confirmed our previous
observations [9] and demonstrated the hepatic insulin resistance
at the gene expression level in ZF rats fed chow ad libitum.
The insulin- and RA-regulated Gck, Pck1 and Srebp-1c
expressions were partially recovered in the primary
hepatocytes from ZF rats fed a VAD diet ad libitum
VA deficiency reduced food intake, body mass, plasma insulin
and triglyceride levels in Zucker rats [9]. Hence, it may attenuate
the impairment of the insulin-regulated gene expression in ZF rat
hepatocytes. Figure 2A (left panel) showed that, in both VAD and
VAS ZL primary hepatocytes, insulin dose-dependently induced
the Gck expression (first and second column clusters), and RA
synergized with insulin to induce its expression (third and fourth
column clusters). The fold inductions of Gck expression by insulin
(marked by *) or by RA + insulin (marked by #) in the VAS ZL
hepatocytes were significantly higher than that in VAD ZL
hepatocytes at the corresponding insulin concentrations. In
comparison, the insulin-induced Gck expression was impaired in
both VAD and VAS ZF hepatocytes regardless of RA (Figure 2A,
right panel).
Insulin dose-dependently suppressed the Pck1 expression in
both VAD and VAS ZL hepatocytes (Figure 2B, left panel, first
and second column clusters). RA induced the Pck1 expression.
Insulin at 1 to 100 nM suppressed the Pck1 expression by over
90% in both VAD and VAS ZL hepatocytes (third and fourth
column clusters, Figure S2B in File S1). The net Pck1 mRNA
levels in the presence of RA were higher than that in the absence
of RA. On the other hand, the insulin-suppressed Pck1 expression
was impaired in VAS ZF hepatocytes. Insulin at 0.1 nM or 1 nM
only suppressed 10% or 40% of the Pck1 expression level,
respectively. However, in VAD ZF hepatocytes, the suppression of
Pck1 expression by 0.1 nM or 1 nM insulin was 40% or 60%,
respectively, suggesting improved regulation by insulin (Figure 2B,
right panel, first and second column clusters, Figure S2A in File
S1). RA induced the Pck1 expression in VAD and VAS ZF
hepatocytes (right panel, third and fourth column clusters). Insulin
at 0.1 nM or 1 nM respectively suppressed the Pck1 expression by
50% or 70% in VAD ZF hepatocytes, which was greater than
20% or 50% in VAS ZF hepatocytes (Figure S2B in File S1).
Insulin dose-dependently induced the Srebp-1c expression, and
RA synergized with insulin to induce its expression in both VAD
and VAS ZL hepatocytes (Figure 2C, left panel). The fold
inductions of Srebp-1c expression by insulin (marked by *) or by
insulin and RA (marked by #) in VAS ZL hepatocytes were
significantly lower than that in VAD ZL hepatocytes. In VAS ZF
hepatocytes, the insulin-induced Srebp-1c expression in the
absence or presence of RA was abolished (Figure 2C, right panel).
Interestingly in VAD ZF hepatocytes, insulin (1 to 100 nM)
partially regained the ability to induce the Srebp-1c expression,
showing improved regulation (first and third cluster).
ZL or ZF rats pair-fed the VAS diet tended to overeat
when sufficient amount of diet was provided
Rats fed a VAD diet after weaning reduced food intakes at
around 5 weeks [13]. To determine how total and acute food
intakes affect the insulin-regulated hepatic gene expression, an 8-
week pair-feeding experiment was designed. Rats were divided
into three groups, VAD-AD, VAS-PF-AD and VAS-PF-4M
(Figure 3A, see Materials and Methods for detail). Figure 3B
shows that VAS-PF-AD ZL and ZF rats ingested 54% and 112%
more food on the last day than VAD-AD ZL and ZF rats did,
respectively, demonstrating the overeating of VAS-PF-AD rats.
The overeating of VAS-PF-AD rats did not significantly increase
the total caloric intake over the entire pair-feeding period
compared to VAD-AD and VAS-PF-4M counterparts (Fig-
ure 3C). Correspondingly, VAS-PF-AD ZL and ZF rats gained
4% and 6% of body mass on the last day, respectively (Figure 3D).
Before sacrifice, the tail tip whole blood glucose levels of VAS-PF-
AD ZF rats were significantly higher than those of VAD-AD and
VAS-PF-4M rats (Figure 3E).
ZL and ZF rats pair-fed the VAS diet had higher body
mass and feed efficiency than their VAD fed counterparts
after the reduction of food intake
During the 56-day pair-feeding regimen, the two-day food
intake of VAD-AD ZL rats gradually increased from ,10 g
initially to ,40 g on days 33–34, and kept relatively stable until
days 41–42 (Figure 4A, left panel). As anticipated [13–15], the
food intake then started to decline until the end of the dietary
manipulation. The two-day food intake of VAD-AD ZF rats
quickly rose from ,10 g initially to ,60 g on days 17–18, leveled
off between days 20 to 34, started to decline on days 35–36,
reached ,30 g on days 47–48, and leveled off again until the end
of the dietary manipulation (right panel). During the same period,
all VAS pair-fed ZL and ZF rats received the same amount of the
isocaloric VAS diet to match the energy intake of VAD-AD rats.
The body mass of VAD-AD ZL and ZF rats ceased to increase
after 36 days of dietary manipulation (Figure 4B). From day 34,
the body mass of VAD-AD ZL or ZF rats was significantly lower
than that of VAS-PF ZL or ZF rats, respectively (marked by *).
Furthermore, the cumulative feed efficiency of all three groups
decreased over time. However, VAS-PF ZL or ZF rats had
significantly higher feed efficiency than VAD-AD ZL or ZF rats
after 36 or 22 days, respectively (Figure 4C).
Transient overeating impaired the insulin-induced Gck
expression in primary hepatocytes of VAS-PF-AD ZL and
ZF rats
In ZL hepatocytes, insulin dose-dependently induced the Gck
expression (Figure 5A). Without or with RA, the fold inductions by
insulin in VAS-PF-AD ZL hepatocytes were significantly lower
than that in VAD-AD hepatocytes (marked by *) and VAS-PF-4M
ZL hepatocytes (marked by $), suggesting an impaired insulin
regulation. Additionally, the fold inductions by insulin in VAD-AD
ZL hepatocytes were lower than that of VAS-PF-4M ZL
hepatocytes without or with RA (marked by #). These results
match the data shown in Figure 2A and indicate that VA status of
ZL rats affects the insulin-stimulated Gck expression in their
hepatocytes.
In ZF hepatocytes, insulin dose-dependently induced the Gck
expression regardless of RA (Figure 5B). Without RA, the fold
inductions by insulin (1 and 10 nM) in VAS-PF-AD ZF
hepatocytes were significantly lower than that in VAS-PF-4M
ZF hepatocytes (Figure 5B, left panel, marked by $). With RA
Vitamin A and Feeding Statuses Modulate Hepatic Insulin Sensitivity
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(Figure 5B, right panel), the fold inductions by insulin in VAS-PF-
AD ZF hepatocytes were significantly lower than that in VAD-AD
(0.1 to 100 nM, marked by *) and VAS-PF-4M (1 to 100 nM,
marked by $) ZF hepatocytes. These data demonstrate the
impairment of the insulin-induced Gck expression in VAS-PF-
AD ZF hepatocytes.
The insulin-suppressed Pck1 expression was partially
impaired in primary hepatocytes of VAS-PF-AD ZL rats
In VAD-AD and VAS-PF-4M ZL hepatocytes, insulin at
0.1 nM suppressed Pck1 expression of by 60% and 70%,
respectively (Figure 6A). The insulin-mediated suppression
reached over 90% at 1 to 100 nM (left panel). In VAS-PF-AD
ZL hepatocytes, the Pck1 expression levels in the presence of 1 to
100 nM insulin were significantly higher than that in VAD-AD
and VAS-PF-4M ZL hepatocytes (marked by * and $, respective-
ly). In the presence of RA, insulin at 0.1 to 100 nM reduced the
elevated Pck1 mRNA levels in all three groups of ZL hepatocytes
(Figure 6A, right panel).
For ZF hepatocytes, insulin at 0.1 to 100 nM significantly
suppressed the Pck1 expression in VAD-AD, VAS-PF-AD and
VAS-PF-4M groups (Figure 6B, left panel). With RA, insulin
reduced the elevated Pck1 mRNA levels in VAS-PF-AD (0.1 to
100 nM), VAD-AD (1 to 100 nM) and VAS-PF-4M (1 to 100 nM)
ZF hepatocytes (right panel). Interestingly, the Pck1 expression
levels in VAS-PF-AD ZF hepatocytes were significantly lower than
Figure 1. Impaired insulin-regulated gene expression in primary hepatocytes of ZF rats fed chow ad libitum. ZL and ZF rats were fed
standard chow for eight weeks before primary hepatocytes were harvested. The primary hepatocytes were incubated in medium A with increasing
concentrations of insulin (0 nM to 100 nM) in the absence or presence of RA (5 mM) for 6 hours. Total RNA was extracted, synthesized into cDNA, and
then subjected to real-time PCR analysis for the expression levels of Gck (A), Pck1 (B), Srebp-1c (C), and Pklr (D). The expression level of each gene
transcript in ZL or ZF hepatocytes treated with vehicle control was arbitrarily set to 1. The data were expressed as fold induction. The numbers of
hepatocyte isolation are presented in parenthesis. All p,0.05; for (A), a9,b9,c9, a,b,c, d9,e9, d,e; for (B), f9.g9.h9, f.g.h, i9.j9, i.k; for (C), l9,
m9,n9, m,o, p9,q9, r,s using one-way ANOVA; * or # for comparing ZL or ZF at corresponding treatments using Student’s t-test, respectively.
doi:10.1371/journal.pone.0100868.g001
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Figure 2. VAD diet partially recovered the impaired insulin-regulated gene expression in ZF primary rat hepatocytes. ZL and ZF rats
were fed either a VAS or VAD diet for 8 weeks. Primary hepatocytes were isolated from rats in ad libitum. Cells were incubated in medium A with
increasing concentrations of insulin (0 nM to 100 nM) in the absence or presence of RA (5 mM) for 6 hours. Total RNA was extracted, synthesized into
cDNA, and then subjected to real-time PCR analysis for the expression levels of Gck (A), Pck1 (B), and Srebp-1c (C). The data were expressed as fold
induction. The gene transcript levels from the no treatment group (0 nM insulin, no RA) for both ZL and ZF were arbitrarily set to 1. The numbers of
hepatocyte isolation are presented in parenthesis. All p,0.05; for (A), a,b,c, d,e,f, g,h,i, j,k,l, m,o, p,r/s/t, q,s/t, r,t, x,y; for (B), a9.b9.
c9, d9.e9.f9, g9.h9.i, j9.k9.l9, m9.n9, o9.q9/r9, p9.r9, s9.t9.u9, v9.x9/y9, w9.y9; for (C), a0,b0,c0, d0,e0,f0, h0,i0,j0, k0,m0, n0,p0, q0,s0,
using one-way ANOVA. * or # for comparing ZL and ZF at corresponding treatments using Student’s t-test, respectively.
doi:10.1371/journal.pone.0100868.g002
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Figure 3. VAS-PF-AD ZL and ZF overate on the last day when sufficient VAS diet was provided. (A) The schematic graph of the setup for
the pair-feeding regimen. VAD ad libitum (VAD-AD, n = 5), VAS pair-feeding last day ad libitum (VAS-PF-AD, n = 5), VAS pair-feeding last day 4 meals
(VAS-PF-4M, n = 5) (B) Tail tip whole blood glucose from ZL and ZF rats before sacrifice. Each circle represents a value from an individual animal. The
bars represent mean 6 S.E.M. * Indicates p,0.05 using one-way ANOVA with LSD post-hoc test. (C) The accumulative food intake for ZL and ZF rats
over 56 days of pair-feeding regimen. (D) The food intake and (E) body mass change for ZL and ZF rats on day 56 of the pair-feeding regimen.
* Indicates p,0.05 using one-way ANOVA with LSD post-hoc test.
doi:10.1371/journal.pone.0100868.g003
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those in VAD-AD ZF hepatocytes at every concentration (marked
by *).
The insulin-induced Srebp-1c expression was impaired by
transient overeating in hepatocytes of VAS-PF-AD ZL and
ZF rats
In VAD-AD and VAS-PF-4M ZL hepatocytes, insulin at 0.1 to
100 nM induced the Srebp-1c expression with or without RA
(Figure 7A). The fold inductions of Srebp-1c by insulin (1 to
100 nM) and insulin + RA (10 to 100 nM) in VAS-PF-AD ZL
hepatocytes were significantly lower than that in VAD-AD
(marked by *) and VAS-PF-4M (marked by $) ZL hepatocytes at
the corresponding treatments.
In VAD-AD and VAS-PF-4M ZF hepatocytes, insulin at 1 to
100 nM induced the Srebp-1c expression with or without RA
(Figure 7B). In contrast, the insulin-mediated inductions of Srebp-
1c expression were abolished in VAS-PF-AD ZF hepatocytes
regardless of RA. As a result, the fold inductions in VAS-PF-AD
ZF hepatocytes were significantly lower than that in VAD-AD
(marked by *) and VAS-PF-4M ZF (marked by $) hepatocytes.
These data demonstrate that the transient overeating of VAS-PF-
AD rats impairs the insulin-induced Srebp-1c expression in their
hepatocytes.
Figure 4. The food intake, body mass and cumulative feed efficiency over 56 days of dietary manipulation. (A) Two-day food intake of
ZL and ZF on VAD ad libitum (VAD-AD, n = 5), VAS-Pair-feeding Last Day ad libitum (VAS-PF-AD, n = 5), VAS-Pair-feeding Last Day 4 meals (VAS-PF-4M,
n = 5) (B) Body mass of ZL and ZF on VAD AD, VAS-PF AD and VAS-PF 4M. (C) Cumulative feed efficiency (unit weight gain per unit diet consumed) of
ZL and ZF on VAD-AD, VAS-PF-AD and VAS-PF-4M. * Indicates p,0.05 using one-way ANOVA with LSD post-hoc test.
doi:10.1371/journal.pone.0100868.g004
Vitamin A and Feeding Statuses Modulate Hepatic Insulin Sensitivity
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Dietary manipulation and VA status regulated the
expression levels of genes for VA metabolism in
hepatocytes from ZL and ZF rats
To understand the impact of transient overeating on the hepatic
VA metabolism, we analyzed the expression levels of key enzymes
for VA metabolism and RA responses in all three groups of ZL
and ZF hepatocytes. As shown in Figure 8A, the expression level
of RBP4 receptor 2 (Rbpr2), a proposed liver-specific retinol
transporter [17], was higher in VAD-AD hepatocytes than that in
VAS-PF-AD and VAS-PF-4M hepatocytes (both ZL and ZF).
RDH2 catalyzes the reversible conversion between retinol and
retinal [18]. In Figure 8A, the expression level of Rdh2 in VAD-
AD ZL or ZF hepatocytes was higher than that in VAS-PF-4M ZL
or ZF hepatocytes, respectively. The expression level of Rdh2 in
VAS-PF-AD ZL hepatocytes was higher than that in VAS-PF-4M,
but lower than that in VAD-AD ZL hepatocytes.
Both RALDH1 (also known as ALDH1A1) and RALDH4 are
involved in the irreversible conversion of retinal into RA [18]. The
Raldh1 (Aldh1a1) expression level in VAS-PF-AD ZL or ZF
hepatocytes was significantly lower than that in VAD-AD and
VAS-PF-4M ZL or ZF hepatocytes, respectively (Figure 8C). The
Raldh4 expression level in VAD-AD ZL hepatocytes was higher
than that in VAS-PF-AD and VAS-PF-4M groups (Figure 8D),
suggesting the alteration of VA metabolism in the liver. However,
the Raldh4 expression levels in all groups of ZF hepatocytes were
similar.
Additionally, the expression level of Cyp26a1 (Figure 8E), a RA
catabolic gene [16,19], in VAD-AD ZL hepatocytes was
significantly lower than that in VAS-PF-AD, but higher than that
in VAS-PF-4M ZL hepatocytes. The Cyp26a1 expression level in
VAD-AD ZF hepatocyte was lower than that in VAS-PF-AD and
VAS-PF-4M ZF groups. The Rarb expression levels were not
different among VAD-AD, VAS-PF-AD, and VAS-PF-4M groups
(Figure 8F).
Two-way ANOVA analysis showed that dietary manipulations
accounted for the majority of overall variance observed in the
expression levels of Rbpr2 (F = 23.04, 61% variance explained),
Rdh2 (F = 13.14, 47%), Raldh1 (F = 23.27, 61%), and Raldh4
(F = 3.56, 22%). This suggests that dietary manipulation can
potentially change the availability of RA in primary hepatocytes
by changing the expression levels of VA metabolic genes. Aside
Figure 5. Insulin-induced Gck expression was attenuated in hepatocytes from VAS-PF-AD, but not VAS-PF-4M rats. The primary
hepatocytes were treated by insulin (0 nM to 100 nM) with or without RA (5 mM) in medium A for 6 hours. The expression level of Gck was
determined by real-time PCR analysis, and the data were expressed as fold induction. The gene transcript levels from the no treatment group (0 nM
insulin, no RA) for both ZL and ZF were arbitrarily set to 1. All p,0.05; for (A), a,b,c, a9,b9,c9, a0,b0,c0, d,e,f, d9,f9/g9, e9,g9, d0,e0,f0; for
(B), h,i,j, h9,i9, h0,i0,j0, k,l,m, j9,k9,l9, k0,i0,m0, using one way ANOVA. *, #, and $ for comparing the effects of dietary manipulations at any
treatment using one way ANOVA.
doi:10.1371/journal.pone.0100868.g005
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from the genes described above, we also checked Stra6, Rdh10,
Raldh2 and Raldh3, whose transcript levels in primary hepato-
cytes were too low to be determined by real-time PCR analysis.
Discussion
Elucidating the molecular mechanisms resulting in hepatic
insulin resistance is of great importance. It helps understand the
development and progression of metabolic diseases. We investi-
gated the effects of food intake and VA status on the insulin-
regulated gene expression in primary hepatocytes of ZL and ZF
rats. ZF rats, which bear a loss-of-function leptin receptor gene,
develop obesity, dyslipidemia and insulin resistance due to
hyperphagia [20]. We found that the insulin-regulated Gck,
Pck1 and Srebp-1c expressions were impaired in the primary
hepatocytes of ZF rats fed chow diet ad libitum (Figure 1),
Figure 6. Transient overfeeding of the VAS diet impaired the insulin-suppressed Pck1 expression in hepatocytes of VAS-PF-AD ZL
rats. The primary hepatocytes were treated by insulin (0 nM to 100 nM) with or without RA (5 mM) in medium A for 6 hours. The expression level of
Pck1 was determined by real-time PCR analysis, and the data were expressed as fold induction. The gene transcript levels from the no treatment
group (0 nM insulin, no RA) for both ZL and ZF were arbitrarily set to 1. All p,0.05; for (A), a.b.c, a9.c9, a0.b0.c0, d.e.g, d.f, d9.f9/g9, e9.g9,
d0.e0.f0.g0; for (B), h.i, h9.i9.j9, h0.i0.j0, k.l, k9.l9.m9, k0.l0, using one way ANOVA. *, #, and $ for comparing the effects of dietary
manipulations at any treatment using one way ANOVA.
doi:10.1371/journal.pone.0100868.g006
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confirming our previous observation [9]. VA deficiency partially
corrected the impairment (Figure 2). We have reported that
retinoids affect the expression levels of several insulin-regulated
genes in primary hepatocytes previously. These observations are
somewhat anticipated and in line with our hypothesis that both
hyperinsulinemia and RA overproduction may take part in the
regulation of the expression of genes for glucose and lipid
metabolism, and contribute to hepatic insulin resistance at the
gene expression level [1].
Compared to ZL rats, ZF rats are hyperinsulinemic [21].
Previous research showed that the insulin binding capacity of the
isolated liver plasma membrane of ZF rats was not different from
that of ZL rats [22]. In addition, the insulin-induced phosphor-
ylation of AKT at Ser473 and Thr308 were similar in the primary
hepatocytes of ZL and ZF rats [9]. These data indicate that the
impairment of insulin-regulated gene expression in ZF hepatocytes
is likely to be caused by alterations downstream of AKT activation
in the insulin signaling cascade. Indeed, VA and insulin operate
through separated pathways to regulate hepatic gene expression.
RA, as a metabolite of VA catabolism, moves to the nucleus and
activates the nuclear receptors (e.g. retinoic acid receptor, retinoid
X receptor, peroxisome proliferator-activated receptor b/d,
hepatocyte nuclear factor 4a, and chicken ovalbumin up-stream
transcription factor II) that are located in the promoters of the
target genes [1]. How these two pathways interact with each other
in normal or disease states deserves further investigation.
We also found that the degree of the impairment of Srebp-1c
expression was more profound than that of Gck and Pck1 in ZF
hepatocytes (Figure 1). It suggests that branching points may exist
in the downstream of insulin signaling pathway, below which the
expressions of Gck, Pck1 and Srebp-1c are differentially regulated
by nutritional and hormonal stimuli. This is in accordance with
other studies. For example, a bifurcation point at mTORC1 in the
insulin signaling pathway separated the insulin-induced Srebp-1c
expression and the insulin-suppressed Pck1 expression [23]. The
knockout of SREBP cleaving-activating protein gene in ob/ob mice
Figure 7. Transient overfeeding of VAS diet impaired insulin-induced Srebp-1c expression in hepatocytes of VAS-PF-AD rats. The
primary hepatocytes were treated by insulin (0 nM to 100 nM) with or without RA (5 mM) in medium A for 6 hours. The expression level of Srebp-1c
was determined by real-time PCR analysis, and the data were expressed as fold induction. The gene transcript levels from the no treatment group
(0 nM insulin, no RA) for both ZL and ZF were arbitrarily set to 1. All p,0.05; for (A), a,b,c,d, a9,b9, a0,b0,c0, e,f, c9,g9/f9, d9,f9, d0,e0,f0; for
(B), g,h, g0,i0/j0, h0,j0, i,k/l, j,l, h9,l9, k0,l0, using one way ANOVA. *, #, and $ for comparing the effects of dietary manipulations at any
treatment using one way ANOVA.
doi:10.1371/journal.pone.0100868.g007
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resulted in the amelioration of hepatic lipogenesis without the
improvement of hepatic gluconeogenesis [24]. Additionally in
primary rat hepatocytes treated with insulin, the Gck expression
reached the peak level 6 hours earlier than did the Srebp-1c
expression [10]. Further studies are needed to dissect these
branching points and discover any change of regulation in insulin
resistance.
The negative effects of short-term overfeeding on the hepatic
insulin sensitivity have been observed in both rodents and humans
with unrevealed mechanisms. The pair-feeding study indicates
that the transient overeating of the VAS diet caused the
impairment of insulin-regulated Gck, Pck1 and Srebp-1c expres-
sions in the primary hepatocytes of ZL rats (Figure 5, 6, 7). In
contrast, VAS-PF-4M ZL rats showed normal insulin-regulated
gene expression. This suggests that, in the liver of so called insulin-
sensitive ZL rats, insulin sensitivity at gene expression level can be
acutely impaired after excessive food intake, and then restored
overtime. Indeed, in young human subjects, a 7-day overfeeding
increased circulating adiponectin and glucagon-like peptide 1
levels, which are proposed to act against the hepatic insulin
resistance [25,26]. On the other hand, transient overeating of the
VAS diet caused worsened impairment of insulin-regulated Gck
and Srebp-1c expressions in the primary hepatocytes of ZF rats
(Figure 5, 7). ZF rats persist in overeating state due to deficient
leptin signaling. This may hamper the restoration of insulin
sensitivity after food intake. As a result, ZF rats fed VAS or chow
ad libitum manifest the hepatic insulin resistance at the gene
expression level.
Long term VA deficiency decreased the insulin-regulated
expression of Gck, but not that of Pck1 and Srebp-1c. In VAS-
PF-AD ZL rats, the insulin-induced Gck expression was signifi-
cantly lower than that in VAS-PF-4M ZL rats (Figure 5), showing
that adequate VA status is instrumental to the insulin-regulated
Gck expression in insulin-sensitive ZL primary hepatocytes. This
observation demonstrates that VA status differentially affects the
hepatic insulin-regulated gene expression, suggesting complex
interactions of VA and insulin signaling systems.
The impairment of insulin-induced Gck (Figure 5) and insulin-
suppressed Pck1 expressions (Figure 6) in VAS-PF-AD hepato-
cytes suggests an elevation of plasma glucose level and an acute
loss of insulin-sensitivity in over-feeding state. This is supported by
the elevated tail tip whole blood glucose level observed in these
animals (Figure 3E), and may explain the elevated hepatic glucose
production in human subjects who are overfed for short terms
[27,28]. The dysregulation of insulin-induced hepatic Srebp-1c
expression after the transient overeating (Figure 7) suggests
increased de novo lipogenesis, which may explain the increased
hepatic fat content observed in short-term overfed humans [29].
More importantly, the impairment was observed in both ZL and
ZF rats after transient overeating. These data suggest the existence
of a mechanism that may dynamically regulate hepatic insulin
sensitivity at the gene expression level in response to feeding status.
Short-term overeating provides excessive intake of not only
calories but also micronutrients. We showed transient overeating
for one day greatly affected the expression levels of genes involved
in VA metabolism in primary hepatocytes of ZL and ZF rats
(Figure 8). VAD-AD rats exhibited high hepatic levels of Rbpr2,
Rdh2, Raldh1 (Aldh1a1) and Raldh4 transcripts, showing
compensatory upregulation of the VA metabolic genes. In
contrast, VAS-PF-4M rats exhibited low hepatic transcript levels
of Rbpr2, Rdh2 and Raldh4. These suggest that the hepatic VA
metabolic gene expression is greatly influenced by the availability
of dietary VA.
VAS-PF-AD rats had lowered hepatic levels of Rbpr2 and
Raldh1 (Aldh1a1) transcripts. Indeed, the Rbpr2 expression is
inversely related to the liver retinol stores, and RA reduces the
Rbpr2 mRNA level in HepG2 cells [17]. Additionally, the elevated
RA controls its biosynthesis by down-regulating RALDH1
(ALDH1A1) through the modulation of retinoic acid receptor a
and CCAAT/enhancer binding protein b [30,31]. These suggest
that the expression levels of VA metabolic genes are modulated in
VAS-PF-AD rats to prevent the RA overproduction in response to
the transient influx of the dietary VA. Despite the negative
feedback regulation, excessive RA may have been produced. This
is supported by the increased expression level of Cyp26a1 [19], a
RA-responsive gene, in VAS-PF-AD hepatocytes (Figure 8E). The
excessive RA may affect the expression of hepatic metabolic genes,
and promote the hepatic insulin resistance at the gene expression
level [1]. It is interesting to note that the VA status does not seem
to affect the expression levels of Raldh1 (Aldh1a1) gene in primary
hepatocytes as its expression levels are similar in VAD-AD and
VAS-PF-4M groups. The underlying mechanism deserves further
investigation.
In summary, we have demonstrated that both VA and feeding
statuses affected the hepatic insulin sensitivity at the gene
expression level. This finding provides insight into the develop-
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